Patent · US Active

Methods and compositions for oral administration of exenatide

US10350162B2 · kind B2 · utility

4Cited by
11References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 2, 2013
Grant dateJul 16, 2019
Priority date—
Expiry dateJun 2, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.